Dr. Chae is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
250 E Superior St
Suite 52261
Chicago, IL 60611Phone+1 855-826-6384
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
- Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2008 - 2011
- Seoul National University College of MedicineClass of 2002
Certifications & Licensure
- FL State Medical License 2024 - Present
- IL State Medical License 2014 - 2026
- TX State Medical License 2011 - 2014
- PA State Medical License 2008 - 2011
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsA Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve-Mutant Metastatic Non-Small Cell Lung...Xiuning Le, Jyoti D Patel, Elaine Shum, Christina Baik, Rachel E Sanborn
Journal of Clinical Oncology. 2025-02-01 - Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma.Sandip P Patel, Eleanor Cano-Linson, Young Kwang Chae, Shiruyeh Schokrpur, Christopher D Lao
NPJ Precision Oncology. 2025-01-24 - A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers.Young Kwang Chae, Lucy Corthell, Sandip Pravin Patel, Robert Edwards, Jennifer M Scalici
Clinical Cancer Research. 2025-01-17
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: